Press releases
- Roche receives FDA clearance on its digital pathology solution for diagnostic use
- Roche and Hitachi High-Tech extend their 46-year partnership, paving the way for further breakthroughs in diagnostic testing
- Roche obtains CE Mark for first companion diagnostic to identify patients with HER2-low metastatic breast cancer eligible for ENHERTU
Key statistics
As of last trade Chugai Pharmaceutical Co Ltd (CUP0:MUN) traded at 17.00, -15.00% below its 52-week high of 20.00, set on Mar 12, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 17.00 |
---|---|
High | 17.00 |
Low | 17.00 |
Bid | 17.00 |
Offer | 17.40 |
Previous close | 16.50 |
Average volume | 0.00 |
---|---|
Shares outstanding | -- |
Free float | -- |
P/E (TTM) | -- |
Market cap | -- |
EPS (TTM) | -- |
Data delayed at least 15 minutes, as of Jul 03 2024 07:10 BST.
More ▼